Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model

Transplant Proc. 1994 Apr;26(2):771-3.

Authors

D R Jeyarajah¹, F S Schmeisser, M A Josephson, D G Sohn, J R Thistlethwaite Jr

Affiliation

¹ Pritzker School of Medicine, Department of Transplantation, Chicago, Illinois 60637.

PMID: 8171656

No abstract available

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
CD3 Complex / immunology*
Diabetes Mellitus, Experimental / surgery*
Graft Survival / drug effects
Graft Survival / physiology*
Immunosuppression Therapy / methods*
Immunosuppressive Agents / therapeutic use*
Islets of Langerhans Transplantation / immunology*
Islets of Langerhans Transplantation / physiology
Lymphocyte Culture Test, Mixed
Lymphocyte Transfusion
Mice
Mice, Inbred C57BL
Rats
Rats, Inbred ACI
Rats, Inbred Lew
Reoperation
Skin Transplantation / immunology
Time Factors
Transplantation, Heterologous / immunology*

Substances

Antibodies, Monoclonal
CD3 Complex
Immunosuppressive Agents